Gates, Milner Back Cancer-Genetics Startup
Microsoft Corp. (MSFT) co-founder Bill Gates and Russian billionaire Yuri Milner invested in genetics startup Foundation Medicine Inc., joining prior backers including Google Ventures and Kleiner Perkins Caufield & Byers.
Gates and Milner helped Foundation raise an additional $13.5 million in an expansion of its Series B financing, bringing the total raised in the round to $56 million, the Cambridge, Massachusetts-based company said today in a statement. Evan Jones, co-founder of Digene Corp., participated in the financing and will join Foundation’s board.
Foundation makes tools that can inspect DNA to determine individuals’ risk of cancer and help doctors make treatment decisions.
To contact the editor responsible for this story: Lisa Rapaport at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.